Further, we have also recently shown that FD patients have increased levels of monocyte chenoattractant protein (MCP-1), keratinocyte chemoattractant (KC), macrophage inflammatory protein-1α (MIP-1α), and the inflammatory cytokine interferon gamma-induced protein-10 (IP-10)6 in their plasma. This evidence concerns the gene CCL2 and Fabry disease.